386 related articles for article (PubMed ID: 29700554)
21. High Potency of
Oliva A; Costantini S; De Angelis M; Garzoli S; Božović M; Mascellino MT; Vullo V; Ragno R
Molecules; 2018 Oct; 23(10):. PubMed ID: 30304862
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial activity of a UV-stable bacteriocin-like inhibitory substance (BLIS) produced by Enterococcus faecium strain DSH20 against vancomycin-resistant Enterococcus (VRE) strains.
Shokri D; Zaghian S; Khodabakhsh F; Fazeli H; Mobasherizadeh S; Ataei B
J Microbiol Immunol Infect; 2014 Oct; 47(5):371-6. PubMed ID: 23838264
[TBL] [Abstract][Full Text] [Related]
23. New antibiotic agents: problems and prospects.
Weber DJ; Rutala WA
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-97-107. PubMed ID: 23577500
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the NanoCHIP® Infection Control Panel test for direct detection and screening of methicillin-resistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria and vancomycin-resistant Enterococcus (VRE).
Weiss J; Arielly H; Ganor N; Paitan Y
Infection; 2015 Jun; 43(3):331-8. PubMed ID: 25725804
[TBL] [Abstract][Full Text] [Related]
25. In vitro susceptibility of multi-drug resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from clinical specimens at Bugando Medical Centre, Tanzania to Piperacillin-Tazobactam.
Petro D; Mushi MF; Moremi N; Iddi S; Mirambo M; Seni J; Mshana SE
Tanzan J Health Res; 2014 Jan; 16(1):54-7. PubMed ID: 26867273
[TBL] [Abstract][Full Text] [Related]
26. In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection.
Cunha MT; Murça MA; Nigro S; Klautau GB; Salles MJC
BMC Infect Dis; 2018 Apr; 18(1):157. PubMed ID: 29614973
[TBL] [Abstract][Full Text] [Related]
27. Antibacterial Activity of Leukocyte- and Platelet-Rich Plasma: An
Cieślik-Bielecka A; Bold T; Ziółkowski G; Pierchała M; Królikowska A; Reichert P
Biomed Res Int; 2018; 2018():9471723. PubMed ID: 30050949
[TBL] [Abstract][Full Text] [Related]
28. An evaluation of the bacteriostatic effect of platelet-rich plasma.
Smith OJ; Wicaksana A; Davidson D; Spratt D; Mosahebi A
Int Wound J; 2021 Aug; 18(4):448-456. PubMed ID: 33476481
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
[No Abstract] [Full Text] [Related]
30. Antimicrobial efficacy and activity of ethanolic extract of Piper betle L. on Staphylococcus aureus-infected wound in mice and clinical isolates of multiple drug-resistant bacterial pathogens.
Valle DLJ; Puzon JJM; Cabrera EC; Cena-Navarro RB; Rivera WL
Trop Biomed; 2021 Jun; 38(2):134-142. PubMed ID: 34172702
[TBL] [Abstract][Full Text] [Related]
31. Bacterial isolation and antibiotic susceptibility from diabetic foot ulcers in Kenya using microbiological tests and comparison with RT-PCR in detection of S. aureus and MRSA.
Mutonga DM; Mureithi MW; Ngugi NN; Otieno FCF
BMC Res Notes; 2019 Apr; 12(1):244. PubMed ID: 31036061
[TBL] [Abstract][Full Text] [Related]
32. Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study.
Bielen L; Likić R; Erdeljić V; Mareković I; Firis N; Grgić-Medić M; Godan A; Tomić I; Hunjak B; Markotić A; Bejuk D; Tičić V; Balzar S; Bedenić B
Croat Med J; 2018 Apr; 59(2):56-64. PubMed ID: 29740989
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
34. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
[TBL] [Abstract][Full Text] [Related]
35. In-vitro release pharmacokinetics of amikacin, teicoplanin and polyhexanide in a platelet rich fibrin-layer (PRF)-a laboratory evaluation of a modern, autologous wound treatment.
Knafl D; Thalhammer F; Vossen MG
PLoS One; 2017; 12(7):e0181090. PubMed ID: 28686663
[TBL] [Abstract][Full Text] [Related]
36. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
Ishikawa K; Hamasuna R; Uehara S; Yasuda M; Yamamoto S; Hayami H; Takahashi S; Matsumoto T; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Deguchi T; Matsumoto M; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Wakeda H; Amemoto Y; Onodera S; Goto H; Komeda H; Yamashita M; Takenaka T; Fujimoto Y; Tsugawa M; Takahashi Y; Maeda H; Onishi H; Ishitoya S; Nishimura K; Mitsumori K; Ito T; Togo Y; Nakamura I; Ito N; Kanamaru S; Hirose T; Muranaka T; Yamada D; Ishihara S; Oka H; Inatomi H; Matsui T; Kobuke M; Kunishima Y; Kimura T; Ichikawa T; Kagara I; Matsukawa M; Takahashi K; Mita K; Kato M; Okumura K; Kawanishi H; Hashimura T; Aoyama T; Shigeta M; Koda S; Taguchi K; Matsuda Y
J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
[TBL] [Abstract][Full Text] [Related]
37. Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro.
Chen L; Wang C; Liu H; Liu G; Ran X
J Diabetes Res; 2013; 2013():269527. PubMed ID: 23671863
[TBL] [Abstract][Full Text] [Related]
38. EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol.
Babu Rajendran N; Gladstone BP; Rodríguez-Baño J; Sifakis F; Voss A; Carmeli Y; Burkert FR; Gkolia P; Tacconelli E
BMJ Open; 2017 Jan; 7(1):e013634. PubMed ID: 28057656
[TBL] [Abstract][Full Text] [Related]
39. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study.
Bielecki TM; Gazdzik TS; Arendt J; Szczepanski T; Król W; Wielkoszynski T
J Bone Joint Surg Br; 2007 Mar; 89(3):417-20. PubMed ID: 17356164
[TBL] [Abstract][Full Text] [Related]
40. Dual Inhibition of
Choi SR; Britigan BE; Narayanasamy P
ACS Infect Dis; 2019 Sep; 5(9):1559-1569. PubMed ID: 31264851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
